Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anna M. Miroshnichenkova"'
Autor:
Anastasia O. Smirnova, Anna M. Miroshnichenkova, Laima D. Belyaeva, Ilya V. Kelmanson, Yuri B. Lebedev, Ilgar Z. Mamedov, Dmitriy M. Chudakov, Alexander Y. Komkov
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
T-cell receptor (TR) diversity of the variable domains is generated by recombination of both the alpha (TRA) and beta (TRB) chains. The textbook process of TRB chain production starts with TRBD and TRBJ gene rearrangement, followed by the rearrangeme
Externí odkaz:
https://doaj.org/article/7c744d23d4c24f8fa70e56c8a7bd5e3e
Autor:
Anastasia O. Smirnova, Anna M. Miroshnichenkova, Laima D. Belyaeva, Ilya V. Kelmanson, Yuri B. Lebedev, Ilgar Z. Mamedov, Dmitriy M. Chudakov, Alexander Y. Komkov
T-cell receptor (TCR) diversity is generated by VDJ recombination. The classical course of TCR beta (TRB) chain production starts with D and J segment recombination and finishes with subsequent recombination between the resulting DJ junction and V se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22300f10850ef2bd5f5b8ae065b2238d
https://doi.org/10.1101/2023.04.21.537904
https://doi.org/10.1101/2023.04.21.537904
Autor:
Anastasia O Smirnova, Anna M Miroshnichenkova, Yulia V Olshanskaya, Michael A Maschan, Yuri B Lebedev, Dmitriy M Chudakov, Ilgar Z Mamedov, Alexander Komkov
Publikováno v:
eLife. 12
High-throughput sequencing of adaptive immune receptor repertoires is a valuable tool for receiving insights in adaptive immunity studies. Several powerful TCR/BCR repertoire reconstruction and analysis methods have been developed in the past decade.
Autor:
Anna M Miroshnichenkova, Michael Maschan, A Komkov, Yulia Olshanskaya, Anastasia O. Smirnova, Alexander Popov, Ilgar Z. Mamedov, Alexander Karachunskiy
Publikováno v:
Blood. 138:4477-4477
Background. Genomic rearrangements of T and B cell receptor genes (BCR and TCR) have become the gold standard marker for clonality assessment and minimal residual disease monitoring (MRD) in acute lymphoblastic leukemia (ALL). B-ALL can bear both TCR